Colorectal Neoplasm Clinical Trial
Official title:
The Usefulness of I-scan in Screening Colonoscopy: A Randomized Controlled Trial
Image-enhanced endoscopy in screening colonoscopy
1. useful tool for detecting subtle epithelial lesions
2. useful tool for predicting real-time histology of epithelial lesions. Among
image-enhancing techniques, i-SCAN is new developed and the practical usefulness of
i-scan for screening colonoscopy has not been investigated yet.
New technologies have been developed to enhance the visualization of colorectal mucosa to
unmask even minute mucosal lesions and identify neoplastic lesion from non-neoplastic
lesions. In particular, there appears to be strong evidence that pan-colonic chromoendoscopy
enhances the detection of colorectal neoplasm in the colon and rectum. However, this
technique is time-consuming because of both the dye spraying and suction of collected dye in
the dependent portion, and therefore it is unsuitable for routine application. To overcome
this inconvenience, optical-digital method involves conversion of the optical
characteristics of the light used for illumination or imaging with a light source differing
in optical characteristics from ordinary white light (WL), such as narrow band imaging
(NBI), Fujinon imaging color enhancement (FICE), auto-fluorescence imaging (AFI) and
infra-red imaging (IRI).
I-scan technology is the newly developed image enhanced endoscopy technology, classified as
a digital contrast method among endoscopic imaging techniques.19 I-scan has three modes of
image enhancement, i.e. surface enhancement (SE); contrast enhancement (CE); and tone
enhancement (TE). The three modes (SE, CE and TE) are arranged in series, therefore, it is
possible to apply two or more of these three modes at one time. Switching the levels or
modes of enhancements can be done on a real-time basis, without any time lag by pushing a
relevant button, thus enabling efficient endoscopic observation. Furthermore, while NBI)
images are much darker than conventional white light (WL) images, i-scan images are as
bright as conventional WL images, therefore, i-scan is able to observe much larger areas in
a distant view compared with NBI. Consequently, i-scan might be more useful for performing
screening endoscopy).
However, the actual usefulness of I-scan in enhancing the detection of colonic neoplastic
lesions is not known yet in screening colonoscopy. Therefore, we tried to evaluate the
hypothesis that, in subjects undergoing colonoscopy screening, the routine application of
i-scan during withdrawal could improve adenoma detection as compared with standard WL
examination.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02244632 -
Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT02057471 -
Intravenous Iron: Measuring Response in Anemic Surgical Patients
|
Phase 4 | |
Terminated |
NCT01074333 -
An Observational Study of Erbitux® in Patients With Metastatic Colorectal Cancer (mCRC) Refractory to Irinotecan-containing Treatment
|
N/A | |
Active, not recruiting |
NCT00506207 -
A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy
|
Phase 1 | |
Recruiting |
NCT05953662 -
Safety and Efficacy of Reduced-port Laparoscopic Surgery for Patients Of Colon and Upper Rectal Cancer
|
N/A | |
Completed |
NCT01959269 -
Investigating the Use of Regorafenib (Stivarga®) in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy
|
N/A | |
Completed |
NCT03559543 -
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
|
Phase 2 | |
Recruiting |
NCT04160832 -
Prevalence and Spectrum of Cancer Susceptibility Among Patients With Advanced Colorectal Polyps
|
||
Terminated |
NCT02961283 -
Study of ASN003 in Subjects With Advanced Solid Tumors
|
Phase 1 | |
Suspended |
NCT02121405 -
Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM
|
Phase 3 | |
Active, not recruiting |
NCT03936530 -
Infrapyloric and Greater Curvature Lymph Node Metastasis in Colon Cancer
|
||
Terminated |
NCT03724071 -
Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors.
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02882620 -
Enhancing Prevention Pathways Toward Tribal Colorectal Health
|
N/A | |
Completed |
NCT00906997 -
Colorectal Cancer Screening in Average-risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy
|
N/A | |
Completed |
NCT00188331 -
Cognitive Function and Fatigue in Colorectal Cancer (CRC) Patients After Chemotherapy
|
N/A | |
Completed |
NCT04786704 -
A Stool DNA Test for Detection of Advanced Colorectal Neoplasia in Asymptomatic Chinese Community Population
|
||
Terminated |
NCT02384850 -
Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer
|
Phase 1 | |
Completed |
NCT01288833 -
Clinical Study of Real Time Colorectal Polyp Diagnosis During Colonoscopy - the VALID Colonoscopy Study
|
N/A | |
Completed |
NCT00001693 -
Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers
|
Phase 1 | |
Recruiting |
NCT03280407 -
NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer
|
Phase 2 |